eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2019
vol. 36
 
Share:
Share:
more
 
 
abstract:
Original paper

Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies

Mazaher Ramezani
1
,
Elisa Zavattaro
2
,
Masoud Sadeghi
3, 4

1.
Molecular Pathology Research Centre, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2.
Dermatology Unit, Department of Translational Medicine, University of Eastern Piedmont “Amedeo Avogadro”, Novara, Italy
3.
Medical Biology Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran
4.
Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
Adv Dermatol Allergol 2019; XXXVI (6): 692-702
Online publish date: 2019/12/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Psoriasis is a T cell-mediated inflammatory skin disease in which fatty acids may be a link between psoriasis and its comorbidity.

Aim
The present meta-analysis aimed to evaluate lipid, lipoprotein, and apolipoprotein levels in the psoriatic patients compared with the control subjects.

Material and methods
Four databases, including Web of Science, Scopus, PubMed, and Cochrane Library were searched until July 2017. All records analysed were case-control studies. The quality of the questionnaires was evaluated using the Newcastle-Ottawa Scale (NOS). A random-effects meta-analysis was done by Rev Man 5.3 using mean difference (MD) and 95% confidence intervals (CIs).

Results
Out of 580 studies identified in four databases, 49 studies were included and analysed in this meta-analysis. The results showed that MD of total cholesterol, triglyceride, LDL, VLDL, HDL, Lp(a), Apo A1, and Apo B levels in the patients compared with the controls were (MD = 13.74 mg/dl; 95% CI: 7.72–19.75; p < 0.00001), (MD = 26.04 mg/dl; 95% CI: 20.77–31.31; p < 0.00001), (MD = 11.41 mg/dl; 95% CI: 6.26–16.57; p < 0.0001), (MD = 4.82 mg/dl; 95% CI: 3.63–6.00; p < 0.00001), (MD = –2.78 mg/dl; 95% CI: –4.53 – –1.03; p < 0.002), (MD = 8.51 mg/dl; 95% CI: 4.86–12.17; p < 0.0001), (MD = –6.60 mg/dl; 95% CI: –13.96 – 0.75; p < 0.08), and (MD = 9.70 mg/dl; 95% CI: 3.02–16.39; p < 0.004), respectively.

Conclusions
This meta-analysis identified abnormality of serum lipid, lipoprotein, and apolipoprotein profiles in psoriatic patients compared with the controls as well as possibly a greater risk of atherosclerosis and cardiovascular (CV) accidents in the patients.

keywords:

psoriasis, serum, lipid, lipoprotein, apolipoprotein

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe